Neogen Corporation (NEOG)
NASDAQ: NEOG · IEX Real-Time Price · USD
12.45
+0.20 (1.63%)
May 2, 2024, 3:59 PM EDT - Market closed

Neogen Revenue

Neogen had revenue of $929.24M in the twelve months ending February 29, 2024, with 28.93% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $228.81M with 4.84% year-over-year growth. In the fiscal year ending May 31, 2023, Neogen had annual revenue of $822.45M with 56.01% growth.

Revenue (ttm)
$929.24M
Revenue Growth
+28.93%
P/S Ratio
2.86
Revenue / Employee
$351,984
Employees
2,640
Market Cap
2.70B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2023822.45M295.29M56.01%
May 31, 2022527.16M58.70M12.53%
May 31, 2021468.46M50.29M12.03%
May 31, 2020418.17M3.98M0.96%
May 31, 2019414.19M16.26M4.09%
May 31, 2018397.93M39.65M11.07%
May 31, 2017358.28M37.00M11.52%
May 31, 2016321.28M38.20M13.50%
May 31, 2015283.07M35.67M14.42%
May 31, 2014247.41M39.88M19.22%
May 31, 2013207.53M23.48M12.76%
May 31, 2012184.05M11.36M6.58%
May 31, 2011172.68M32.17M22.90%
May 31, 2010140.51M21.79M18.35%
May 31, 2009118.72M16.30M15.92%
May 31, 2008102.42M16.28M18.90%
May 31, 200786.14M13.71M18.92%
May 31, 200672.43M9.68M15.42%
May 31, 200562.76M7.26M13.08%
May 31, 200455.50M7.81M16.38%
May 31, 200347.69M5.62M13.36%
May 31, 200242.07M7.17M20.55%
May 31, 200134.90M11.38M48.41%
May 31, 200023.51M1.33M6.01%
May 31, 199922.18M3.69M19.96%
May 31, 199818.49M3.23M21.16%
May 31, 199715.26M2.77M22.17%
May 31, 199612.49M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 3.00B
Premier 1.32B
PTC Therapeutics 927.56M
MorphoSys AG 264.75M
Arcellx 110.32M
Rhythm Pharmaceuticals 77.43M
Merus 43.95M
Celldex Therapeutics 6.88M
Revenue Rankings